top of page

Nelson Advisors: This Week in European HealthTech, MedTech and Health AI: 18th September 2026

Writer: Nelson Advisors
Nelson Advisors
8 minutes ago
5 min read
Nelson Advisors: This Week in European HealthTech, MedTech and Health AI: 18th September 2026
Nelson Advisors: This Week in European HealthTech, MedTech and Health AI: 18th September 2026

European HealthTech continues to see heavy capital flow toward clinical workflow automation, platform consolidation and regulatory alignment under evolving EU frameworks.


Late Stage Rounds & Clinical Automation


  • Tandem Health (Sweden) raised $100M in Series B funding, backed by the EU's €5B tech startup initiative, to scale its clinical workflow and administrative AI platform across European healthcare networks.


  • Holifya (Italy) closed a €2M round to expand its AI-assisted digital clinic model targeting metabolic health and GLP-1 therapy adherence, demonstrating continued niche appetite for integrated virtual clinic platforms.


  • Venture capital continues shifting decisively away from standalone consumer wellness apps, heavily prioritising deep-tech diagnostics, trial infrastructure, and "clinical plumbing" (such as Qureight and Ahead Health).


M&A, Platform Building & Cross Border Expansion


  • Hygie31 acquired a majority stake in Ireland's Navi Group, expanding the French pharmacy and healthcare platform into English-speaking Europe to consolidate fragmented dispensing and care services.


  • HCML acquired Corazon Health (UK), continuing its buy-and-build strategy to construct a centralised, tech-enabled occupational health and rehabilitation network.


  • AddLife (Sweden) acquired Unicam Sistemas Analíticos (Portugal), expanding its distribution footprint in high-throughput laboratory tech and automated diagnostics.

    Investors in Healthcare


Policy & Implementation Shifts


  • NHS Ambient Voice Technology (AVT): UK trust rollouts are picking up pace under the national digital health modernisation initiative, favouring vendors with direct electronic health record (EHR) integration.


  • EU AI Act & Medical Software: Health systems are adjusting compliance pipelines following recent Digital Omnibus adjustments. While patient-facing interactive bots face strict transparency disclosures, embedded diagnostic and SaMD (Software as a Medical Device) models are harmonizing with the MDR roadmap, deferring duplicate conformity burdens toward 2027/2028.

    Nelson Advisors


Policy & Procurement Reform


  • EU Public Procurement Overhaul: The European Commission introduced its proposal for a new Public Procurement Regulation, establishing the "best price-quality ratio" as the default standard to phase out lowest-price purchasing. Trade body MedTech Europe responded, advocating for a quality weighting higher than the proposed 30% minimum and warning against strict "Made in Europe" component-origin preferences that could disrupt multinational supply chains.


  • MDR/IVDR Digitisation & Streamlining: The European Commission and notified body association Team-NB advanced a €4M project to digitise MDR and IVDR conformity assessment procedures. Additionally, the Commission expanded its Well-Established Technologies (WET) list across roughly 55 legacy medical device categories to reduce redundant certification backlogs.


  • Digital Omnibus Clarifications: Regulatory guidance confirmed that high-risk software-as-a-medical-device (SaMD) subject to both the EU AI Act and MDR/IVDR conformity assessments will follow deferred assessment milestones toward late 2027 to prevent duplication and notified body bottlenecks.


Clinical Clearances & Commercial Milestones


  • FemPulse Ring CE Mark: Bioelectronic developer FemPulse secured CE Mark clearance under the EU MDR for its non-invasive neuro-modulation ring targeting overactive bladder, opening distribution across EU member states.


  • Joint Clinical Assessments (JCA): National authorities and notified bodies initiated preliminary workflows for the first wave of medical devices navigating the centralised EU-wide Health Technology Assessment (HTA) framework.


Venture Funding & Hardware Innovation


  • Xeltis (€20.5M): The Dutch clinical-stage MedTech firm secured funding to accelerate clinical development of its bio-absorbable, restorative cardiovascular implants and vascular access grafts.


  • Onalabs (€9.3M Series A): Spanish biometric hardware developer Onalabs raised capital to expand its medical-grade, non-invasive continuous sweat-monitoring wearable for clinical and remote patient monitoring.


  • Strolll (€5M): UK-based neuro-rehabilitation provider closed combined equity and grant funding to expand hospital deployment of its augmented-reality and computer-vision physical therapy systems.


Funding & Commercial Deployments


  • Tandem Health ($100M Series B): Swedish clinical AI assistant Tandem Health secured $100 million led by the Scaleup Europe Fund (managed by EQT). The capital is earmarked to evolve its ambient scribe from consultation documentation into an autonomous, AI-native clinic operating system managing triage and patient flows across 14 European countries.


  • Penelope Health (€87M): London-based Penelope Health raised €87 million alongside an infrastructure integration with Thoreau to automate payer rules, claims processing, and clinical revenue-cycle intelligence across European provider networks.


  • Big Picture Bio (€2.55M): London-based computational biology startup Big Picture Bio emerged from stealth to deploy foundation models for designing synergistic multi-target cancer drug combinations.


Adoption & Market Benchmarks


  • AWS European Healthcare AI Adoption Index: A pan-European industry study released this week showed that while healthcare adoption lags the cross-industry average (41% vs. 54%), healthcare adopters report disproportionately higher returns, with 60% noting revenue expansion and 55% citing significant productivity gains. However, 54% cited an acute workforce digital skills shortage as the primary impediment to scaling.


Governance & Regulatory Action


  • EU Neuro-AI Infrastructure Framework: The European Group on Ethics in Science and New Technologies (EGE) published formal recommendations urging the European Commission to shift neuro-AI regulation from standalone device privacy to an infrastructure-level model. The proposal focuses on protecting sovereign neuro-data pools, governing synthetic neural inferences, and establishing public-interest standards for Brain Foundation Models.


  • MDR / AI Act Harmonisation Readiness: With initial AI Act transparency rules for conversational and synthetic systems now in effect, hospital procurement teams and notified bodies have begun auditing generative clinical assistants. High-risk clinical diagnostic models continue updating single-file technical documentation ahead of the streamlined MDR integration timelines.


Nelson Advisors > European HealthTech, MedTech, Digital Health Investment Banking

 

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, MedTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies.www.nelsonadvisors.co.uk


Nelson Advisors regularly publish Thought Leadership articles covering market insights, industry trends, deal commentary, market analysis & predictions @ https://www.healthcare.digital 


Nelson Advisors publish Europe's Leading Healthcare Technology Investment Banking Newsletter every week, join 5000+ HealthTech and MedTech subscribers today! https://lnkd.in/e5hTp_xb 


Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards, corporates, venture capital and private investors to maximise shareholder value and investment returns.www.nelsonadvisors.co.uk



Nelson Advisors LLP

 

Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT




Meet Nelson Advisors @ 2026 Events

 

Digital Health Rewired > March 2026 > Birmingham, UK 

 

NHS ConfedExpo  > June 2026 > Manchester, UK 

 

HLTH Europe > June 2026, Amsterdam, Netherlands

 

HIMSS AI in Healthcare > July 2026, New York, USA

 

Bits & Pretzels > September 2026, Munich, Germany  

 

World Health Summit 2026 > October 2026, Berlin, Germany

 

HealthInvestor Healthcare Summit > October 2026, London, UK 


HLTH USA 2026 > October 2026, USA

 

Barclays Health Elevate > October 2026, London, UK 

 

Web Summit 2026 > November 2026, Lisbon, Portugal  

 

MEDICA 2026 > November 2026, Düsseldorf, Germany

 

Venture Capital World Summit > December 2026 Toronto, Canada


Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, MedTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies.www.nelsonadvisors.co.uk
Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, MedTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies.www.nelsonadvisors.co.uk

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page